<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The remarkable effect of plasma exchange (PE) was observed on <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> in a patient with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) associated with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Three times PE led to recovery from severe <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> refractory to treatment with <z:chebi fb="0" ids="50858">corticosteroid</z:chebi>, <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, and antiplatelet drugs accompanied by a decrease in the serum <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> beta2 <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibody level </plain></SENT>
<SENT sid="2" pm="."><plain>This result suggests that PE is a valuable therapeutic tool for refractory <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> in APS </plain></SENT>
</text></document>